Literature DB >> 19207715

Ischaemic post-conditioning protects both adult and aged Sprague-Dawley rat heart from ischaemia-reperfusion injury through the phosphatidylinositol 3-kinase-AKT and glycogen synthase kinase-3beta pathways.

Zhong Yin1, Haokao Gao, Haichang Wang, Lansun Li, Chunxia Di, Ronghua Luan, Ling Tao.   

Abstract

1. Numerous studies have demonstrated that ischaemic post-conditioning (IPoC) protects adult rats from myocardial ischaemia-reperfusion (I/R) injury. Recent evidence suggests compromised cardioprotection by IPoC in aged mice. The present study was designed to test the hypothesis that IPoC protects against I/R injury in aged hearts, potentially through a phosphatidylinositol 3-kinase (PI3-K)-Akt- and glycogen synthase kinase (GSK)-3beta-dependent mechanism. 2. Hearts from adult (3-4 months) or aged (16-18 months) Sprague-Dawley rats were subjected in vivo to 30 min ischaemia followed by 3 h reperfusion. Ischaemic post-conditioning (four cycles of 10 s reperfusion-10 s ischaemia) was applied at the beginning of reperfusion, either alone or in combination with the PI3-K inhibitor LY294002 (0.3 mg/kg). Infarct size and the phosphorylation of Akt and GSK-3beta were determined. 3. Ischaemic post-conditioning reduced infarct size in both adult and aged rat hearts. This protection was accompanied by a significant increase in phosphorylation of Akt and GSK-3beta. LY294002 abolished the IPoC-induced phosphorylation of Akt and GSK-3beta, as well as the infarct-limiting effect of IPoC in adult and aged rats. In addition, IPoC significantly attenuated plasma concentrations of creatine kinase and lactate dehydrogenase after reperfusion in both adult and aged rats. 4. In conclusion, IPoC, at the onset of reperfusion, reduces myocardial infarct size in both adult and aged rat hearts, potentially through a PI3-K-, Akt- and GSK-3beta-dependent mechanism.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19207715     DOI: 10.1111/j.1440-1681.2009.05148.x

Source DB:  PubMed          Journal:  Clin Exp Pharmacol Physiol        ISSN: 0305-1870            Impact factor:   2.557


  13 in total

1.  Endogenous cardioprotection by ischaemic postconditioning and remote conditioning.

Authors:  Weiwei Shi; Jakob Vinten-Johansen
Journal:  Cardiovasc Res       Date:  2012-02-09       Impact factor: 10.787

Review 2.  Ischaemic conditioning: pitfalls on the path to clinical translation.

Authors:  Karin Przyklenk
Journal:  Br J Pharmacol       Date:  2015-02-27       Impact factor: 8.739

Review 3.  Efficacy of cardioprotective 'conditioning' strategies in aging and diabetic cohorts: the co-morbidity conundrum.

Authors:  Karin Przyklenk
Journal:  Drugs Aging       Date:  2011-05-01       Impact factor: 3.923

4.  Preconditioning the human brain: practical considerations for proving cerebral protection.

Authors:  Sebastian Koch
Journal:  Transl Stroke Res       Date:  2010-09       Impact factor: 6.829

5.  Ischemic post-conditioning reduces infarct size of the in vivo rat heart: role of PI3-K, mTOR, GSK-3beta, and apoptosis.

Authors:  Claudia Wagner; Diana Tillack; Gregor Simonis; Ruth H Strasser; Christof Weinbrenner
Journal:  Mol Cell Biochem       Date:  2010-01-07       Impact factor: 3.396

6.  Uncoupled eNOS annihilates neuregulin-1β-induced cardioprotection: a novel mechanism in pharmacological postconditioning in myocardial infarction.

Authors:  Bernd Ebner; Stefan A Lange; Thomas Eckert; Clementine Wischniowski; Annette Ebner; Rüdiger C Braun-Dullaeus; Christof Weinbrenner; Carsten Wunderlich; Gregor Simonis; Ruth H Strasser
Journal:  Mol Cell Biochem       Date:  2012-10-12       Impact factor: 3.396

Review 7.  Protective ischaemia in patients: preconditioning and postconditioning.

Authors:  Asger Granfeldt; David J Lefer; Jakob Vinten-Johansen
Journal:  Cardiovasc Res       Date:  2009-04-27       Impact factor: 10.787

Review 8.  Ageing, sex, and cardioprotection.

Authors:  Marisol Ruiz-Meana; Kerstin Boengler; David Garcia-Dorado; Derek J Hausenloy; Tuuli Kaambre; Georgios Kararigas; Cinzia Perrino; Rainer Schulz; Kirsti Ytrehus
Journal:  Br J Pharmacol       Date:  2020-02-03       Impact factor: 8.739

9.  Cardioprotective effects of tanshinone IIA pretreatment via kinin B2 receptor-Akt-GSK-3β dependent pathway in experimental diabetic cardiomyopathy.

Authors:  Dongdong Sun; Min Shen; Jiayi Li; Weijie Li; Yingmei Zhang; Li Zhao; Zheng Zhang; Yuan Yuan; Haichang Wang; Feng Cao
Journal:  Cardiovasc Diabetol       Date:  2011-01-13       Impact factor: 9.951

10.  Influence of cardiovascular risk factors on infarct size and interaction with mechanical ischaemic postconditioning in ST-elevation myocardial infarction.

Authors:  Sophie Pichot; Nathan Mewton; Theodora Bejan-Angoulvant; Francois Roubille; Gilles Rioufol; Céline Giraud; Inesse Boussaha; Olivier Lairez; Meyer Elbaz; Christophe Piot; Denis Angoulvant; Michel Ovize
Journal:  Open Heart       Date:  2015-08-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.